Assessment of cardiovascular risk in patients with primary chronic gout combined with metabolic syndrome

Abstract

Background. The purpose of the study is to ivestigate the frequency of metabolic syndrome (MS) and to assess the total cardiovascular risk in patients with primary chronic gout, depending on the presence of MS. Materials and methods. Eighty-two patients with primary chronic gout, diagnosed with the qualification criteria of S.J. Wallase et al., were examined. The basic group included patients with primary chronic gout with MS (n = 52), which accounted for 63.4 % of all surveyed persons. The MS was diagnosed by IDF criteria. The comparison group involved patients with MS, matched by sex and age (n = 46). Clinical (anthropometric parameters, blood pressure) and laboratory examination (level of fasting glycaemia, uric acid, lipid, oral glucose tolerance test) took into account the presence of cardiovascular disease in medical history and its complications, evaluated cardiovascular risk on SCORE and PROCAM scales. Results. The incidence of obesity in the study groups was 65.4 and 63.0 %, respectively. The frequency of additional MS criteria was high in both groups studied. Hypertension and hypertriglyceridemia were equally often diagnosed in patients with MS regardless of the presence of gouty arthritis (p < 0.01). At least one additional MS criterion was detected in all those patients surveyed. 28.8 % of patients in the basic group and 4.3% patients in the comparison group were diagnosed with all five additional MS criteria (p < 0.01). In the patients of the basic group more than three additional MS criteria were identified compared to the comparison group — 51.9 and 30.4 %, respectively. The total cardiovascular risk on SCORE and PROCAM scales in patients in the basic group was significantly higher than in the comparison group (p < 0.05 and p < 0.01, respectively). Conclusions. MS was diagnosed in 63.4 % of patients with primary chronic gout. The patients with primary chronic gout combined with MS have a higher total cardiovascular risk on SCORE and PROCAM scales compared to patients with MS only. Evaluation of MS criteria, together with the assessment of cardiovascular risk, can be used in routine clinical practice to stratify patients with primary chronic gout who need lifestyle modifications and/or differentiated approaches to medical treatment.

Authors and Affiliations

A. O. Cherniaieva, M. R. Mykytyuk, Y. I. Karachentsev, N. O. Kravchun

Keywords

Related Articles

Pathogenetic and clinical correlation of type 2 diabetes mellitus with metabolic syndrome and chronic coronary artery disease

Background. Increase of morbidity of diabetes mellitus (DM) associated with coronary artery disease (CAD) on the background of metabolic syndrome (MS) is worrisome. It is very important to improve the diagnosis of this a...

The content of ghrelin and leptin in the blood plasma of children and adolescents with hypothalamic dysfunction

Background. The purpose of the study was to carry out a comparative analysis the levels of leptin and ghrelin in the blood plasma of children and adolescents with hypothalamic dysfunction and various forms of obesity. Ma...

Congenital Hyperinsulinism: the Possibilities of Modern Diagnosis and Treatment

Congenital hyperinsulinism (CHI) — one of the main causes underlying the development of persistent hypoglycemic conditions in childhood. The article presents the experience of diagnosis and treatment in patients with CHI...

Analysis of Medical Status of Patients with Type 2 Diabetes Mellitus and Its Impact on the Development of Complications

The assessment of quality of diabetes care in the implementation of new clinical protocol is an urgent problem. The objective of the study — to assess the medical status of patients with type 2 diabetes mellitus accordin...

acuum Therapy of Diabetic Soft Tissue Wounds: the Impact on the Matrix Metalloproteinase Activity

The objective was to investigate the effect of vacuum therapy on the main stages of the healing of purulent wounds of soft tissues in patients with diabetes mellitus, the degree of microbial contamination of wounds and t...

Download PDF file
  • EP ID EP630809
  • DOI 10.22141/2224-0721.15.4.2019.174815
  • Views 49
  • Downloads 0

How To Cite

A. O. Cherniaieva, M. R. Mykytyuk, Y. I. Karachentsev, N. O. Kravchun (2019). Assessment of cardiovascular risk in patients with primary chronic gout combined with metabolic syndrome. Міжнародний ендокринологічний журнал, 15(4), 298-303. https://europub.co.uk/articles/-A-630809